Core Laboratories

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$134,397
$130,577
$129,637
$128,210
Gross Profit
23,916
23,877
21,206
22,819
EBITDA
23,479
17,388
12,414
18,028
EBIT
19,803
13,618
8,571
14,154
Net Income
11,745
9,032
3,220
6,462
Net Change In Cash
134,397
130,577
129,637
128,210
Free Cash Flow
10,371
14,213
2,475
16,634
Cash
21,474
17,695
14,913
15,119
Basic Shares
47,820
47,743
47,703
47,557

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$509,790
$489,735
$470,252
$487,267
Gross Profit
94,049
78,919
83,840
91,633
EBITDA
70,424
58,685
63,778
-56,502
EBIT
54,640
41,524
45,262
-77,369
Net Income
36,675
19,453
19,727
-97,073
Net Change In Cash
509,790
489,735
470,252
487,267
Cost of Revenue
-2,275
3,897
2,714
Free Cash Flow
14,210
14,740
23,040
45,988
Cash
15,120
15,428
17,703
13,806
Basic Shares
47,523
46,813
46,690
44,974

Earnings Calls

Quarter EPS
2024-09-30
$0.25
2024-06-30
$0.22
2024-03-31
$0.19
2023-12-31
$0.19